Synfacts, Table of Contents Synfacts 2022; 18(09): 1028DOI: 10.1055/s-0041-1738562 Innovative Drug Discovery and Development Iezoside – A New and Potent SERCA inhibitorContributor(s): Dirk Trauner , Klaus-Peter RuehmannRecommend Article Abstract Buy ArticleKey words Key wordsEvans aldol reaction - Babler–Dauben–Michno oxidative transposition - Schmidt glycosylation - SERCA inhibitors Full Text